previous compound ID: 303 next compound
InChIKey: BZKPWHYZMXOIDC-UHFFFAOYSA-N
SMILES: CC(=O)NC1=NN=C(S1)S(=O)(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "J Liao" "E Matthes" "SD Macknight" "GW Carlile" "JW Hanrahan" "R Robert" "B Kus" "D Rotin" "J Goepp"

chemical graph of compound 303





CID is 1986
synonyms found at PubChem are:
acetazolamide, 59-66-5, Diamox, Acetazolamid, Diacarb, Glaupax, N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide, Defiltran, Nephramide, Acetamox, Cidamex, Diluran, Edemox, Dehydratin, Diuramid, Diutazol, Duiramid, Eumicton, Natrionex, Nephramid, Phonurit, Diakarb, Donmox, Fonurit, Glupax, Vetamox, Didoc, SK-acetazolamide, Diuriwas, Acetazolamida, Acetazolamidum, Acetazoleamide, Acetozalamide, Diureticum-holzinger, Acetamidothiadiazolesulfonamide, 5-Acetamido-1,3,4-thiadiazole-2-sulfonamide, Acetazolamine, Acetazolam, Atenezol, Diuramide, Glaumox, Diamox Sequels, Apo-Acetazolamide, 4-Diamox, Ak-Zol, Carbonic Anhydrase Inhibitor No. 6063, 2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide, Acetazolamidum [INN-Latin], Acetazolamida [INN-Spanish], Acetamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-, Storzolamide, Dazamide, Carbonic anhydrase inhibitor 6063, UNII-O3FX965V0I, 2-Acetamido-5-sulfonamido-1,3,4-thiadiazole, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide, NSC 145177, 1,3,4-Thiadiazole-2-sulfonamide, 5-acetamido-, Diamox (TN), Acetazolamide [INN:BAN:JAN], C4H6N4O3S2, CCRIS 5811, Acetazolamide (AAZ), Acetazolamide Sodium, (Sterile), HSDB 3002, 5-Acetamide-1,3,4-thiadiazole-2-sulfonamide, CHEMBL20, Acetazolamide sodium, EINECS 200-440-5, N-(5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide, AI3-52458, MLS000028435, O3FX965V0I, CHEBI:27690, BZKPWHYZMXOIDC-UHFFFAOYSA-N, Acetazolamide, Monosodium Salt, Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-, CAS-59-66-5, NCGC00015074-10, Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-, SMR000058394, DSSTox_CID_2544, 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide, A 6011, DSSTox_RID_76621, DSSTox_GSID_22544, N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-acetamide, N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide, N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide, Acetadiazol, Glauconox, HumaZolamide, ApoAcetazolamide, Huma Zolamide, Huma-Zolamide, AkZol, Apo Acetazolamide, Acetazolamide Related Compound (5-acetamido-1,3,4-thiadiazole-2-sulfonic acid), Ak Zol, N-[5-Sulfamoyl-1,3,4-thiadiazol-2-yl]acetamide, SR-01000000065, DiamoxSequels, Prestwick_4, 1azm, 1yda, 1ydb, 1ydd, 1zsb, 2xtk, 3czv, 3ucj, Acetazolamide, 5, Acetazolamide [USP:INN:BAN:JAN], Acerazolamide, AAZ, Acetazolamide, AAZ, Acetazolamide, AZA, Acetazolamide, AZM, ACMC-20gwkd, PubChem12858, Spectrum_000018, 1jd0, 2h4n, 2uy4, 3dc3, 3hs4, 3ml5, 4g0c, Acetazolamide ICN Brand, Opera_ID_288, Acetazolamide Grin Brand, AZA2, Acetazolamide Jumer Brand, Acetazolamide Orion Brand, Prestwick0_000003, Prestwick1_000003, Prestwick2_000003, Prestwick3_000003, Spectrum2_000082, Spectrum3_000284, Spectrum4_000139, Spectrum5_000738, Lopac-A-6011, Acetazolamide Apotex Brand, Acetazolamide Chiesi Brand, Acetazolamide Dioptic Brand, Acetazolamide Llorens Brand, D0E1SW, ICN Brand of Acetazolamide, AC1L1CO5, Grin Brand of Acetazolamide, Acetazolamide Medphano Brand, Jumer Brand of Acetazolamide, Orion Brand of Acetazolamide, Acetazolamide Novopharm Brand, Lopac0_000039, Monosodium Salt Acetazolamide, SCHEMBL23219, BSPBio_000005, BSPBio_001788, KBioGR_000558, KBioSS_000358, Apotex Brand of Acetazolamide, Chiesi Brand of Acetazolamide, KSC270I0P, MLS001148438, Acetazolamide Wassermann Brand, BIDD:GT0643, DivK1c_000017, SPECTRUM1500102, Dioptic Brand of Acetazolamide, Llorens Brand of Acetazolamide, SPBio_000004, SPBio_001926, BPBio1_000007, GTPL6792, Medphano Brand of Acetazolamide, (non-d)Acetazolamide-13C2-d3, Acetazolamide, >=99%, powder, DTXSID7022544, Novopharm Brand of Acetazolamide, SCHEMBL11049053, BDBM10880, BZKPWHYZMXOIDC-UHFFFAOYSA-, CTK1H0407, HMS500A19, KBio1_000017, KBio2_000358, KBio2_002926, KBio2_005494, KBio3_001288, KS-00000UPN, Acetazolamide (JP15/USP/INN), Acetazolamide (JP17/USP/INN), N-[5-(Aminosulfonyl)-1,3,4-thiadiozol-2-yl]-Acetamide, Wassermann Brand of Acetazolamide, Acetazolamide, analytical standard, MolPort-001-783-578, NINDS_000017, HMS1568A07, HMS1920A05, HMS2091G05, HMS2095A07, HMS2232G23, HMS3259I13, HMS3260G19, HMS3370P01, HMS3712A07, Pharmakon1600-01500102, WLN: T5NN DSJ CSZW EMV1, Ciba Vision Brand of Acetazolamide, ALBB-023617, EBD55026, HY-B0782, ZINC3813042, Tox21_110078, Tox21_201559, Tox21_302773, Tox21_500039, CCG-38900, MFCD00003105, NSC145177, NSC755854, s4506, SBB056640, AKOS000715163, Tox21_110078_1, AN-5544, CS-3568, DB00819, LP00039, MCULE-4029778803, NC00491, NSC-145177, NSC-755854, IDI1_000017, Storz Brand of Acetazolamide Preparation, Wyeth Brand of Acetazolamide Preparation, 1424-27-7 (mono-hydrochloride salt), NCGC00015074-01, NCGC00015074-02, NCGC00015074-03, NCGC00015074-04, NCGC00015074-05, NCGC00015074-06, NCGC00015074-07, NCGC00015074-08, NCGC00015074-09, NCGC00015074-11, NCGC00015074-12, NCGC00015074-14, NCGC00015074-15, NCGC00023455-03, NCGC00023455-04, NCGC00023455-05, NCGC00023455-06, NCGC00023455-07, NCGC00256374-01, NCGC00259108-01, NCGC00260724-01, AC-12779, AS-13169, BAS 01585728, CJ-10773, CPD000058394, H501, LS-10227, SAM002554883, SC-20738, SBI-0050028.P004, 2-Acetamido-5-sulfonamido-1,4-thiadiazole, 5-Acetamide-1,4-thiadiazole-2-sulfonamide, 2-Acetamido-5-sulfamoyl-1,3,4-thiadiazole, 5-Acetamido-1,3,4-thiadiazol-2-sulfonamide, AB00051906, EU-0100039, FT-0621733, R1055, ST45022057, 1,4-Thiadiazole-2-sulfonamide, 5-acetamido-, C06805, D00218, J10059, 20506-EP2269989A1, 20506-EP2275420A1, 20506-EP2280008A2, 20506-EP2295406A1, 20506-EP2298772A1, 20506-EP2308562A2, 20506-EP2308839A1, 20506-EP2314585A1, AB00051906_15, 003A105, A832415, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide, 2-ACETAMINO-1,3,4-THIADIAOLE-5-SULFONAMIDE, I09-0425, N-[5-Sulfamoyl-1,3,4-thiadiazol- 2-yl]acetamide, Q-200579, Q-200580, SR-01000000065-2, SR-01000000065-4, SR-01000000065-6, BRD-K43457670-001-22-9, BRD-K43457670-001-26-0, Z277559108, Acetazolamide, European Pharmacopoeia (EP) Reference Standard, Acetazolamide, United States Pharmacopeia (USP) Reference Standard, N - (5 - Sulfamoyl - 1,3, 4 - thiadiazol - 2 - yl) acetamide, Acetazolamide for system suitability, European Pharmacopoeia (EP) Reference Standard, 2-Acetamido-5-sulfamoyl-1,3,4-thiadiazole; 2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide; 5-Acetamido-1,3,4-thiadiazole-2-sulfonamide, 5661-25-6, 8017-69-4, InChI=1/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)